Leading Sponsor Delivers Enrollment 24 Months Ahead Of Schedule

Challenge
A leading pharma company needed to get their enrollment back on track. Their 100-patient Phase II dermatology study had been underway for 11 months across 32 sites globally, but only 20 subjects had been enrolled to date. The client had heavily invested in a traditional recruitment vendor, which had only yielded two newly enrolled patients. With the objective of getting back on schedule, the sponsor partnered with WCG in fundamentally helping their sites meet their full potential.